The Spectranetics Corp

The Spectranetics — Spectranetics — FY2009 Earnings Presentation

14 slides from The Spectranetics's earnings presentation, Feb 18, 2010

  1. Slide 1: Fourth Quarter and Full Year Results Conference Call

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 1 Nasdaq: SPNC Spectranetics Fourth Quarter and Full Year Results Conference Call February 18, 2010

  2. Slide 2: 2009 Accomplishments

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 2 2009 Accomplishments Resolved the matters arising from the federal investigation Achieved revenue growth of 10% compared with 2008 Achieved pre-tax profit, adjusted for special items, in each of the last two quarters * CELLO data pub

  3. Slide 3: 2009 Accomplishments

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 3 2009 Accomplishments Launched Quick Cross Select (Extreme) Launched ThromCat XT in Europe Received FDA clearance and EU approval for VisiSheath Submitted site change notification to FDA for relocation of PMA products to new facility

  4. Slide 4: 2009 Accomplishments

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 4 2009 Accomplishments Expanded international presence to 40 countries at end of 2009 compared with 34 at end of 2008 Restructured the organization, reducing overhead by $1.6 million Relocated all 510k products to new facility Transfer

  5. Slide 5: Annual Revenue (millions)

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 5 2007 2008 2009 82.9 104 114.8 Annual Revenue (millions)

  6. Slide 6: Annual Disposable Product Revenue (millions)

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 6 2007 2008 2009 68.6 86.3 98.7 Annual Disposable Product Revenue (millions)

  7. Slide 7: Annual Other Revenue (millions)

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 7 2007 2008 2009 Laser Sales 3.3 4.5 2.1 Laser Rental 3 4.1 4.7 Service & Other 7.9 9 9.3 Annual Other Revenue (millions) $14.2 $17.7 $16.1

  8. Slide 8: International

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 8 International Revenue (millions) 2007 2008 2009 International 9.9 13.7 17.9

  9. Slide 9: Lead Management

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 9 Lead Management Revenue (millions) 2007 2008 2009 Lead Management 21.2 28.9 36.8

  10. Slide 10: Vascular Intervention

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 10 Vascular Intervention Revenue (millions) 2007 2008 2009 Vascular Intervention 47.5 57.4 61.9

  11. Slide 11: Atherectomy

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 11 Atherectomy Revenue (millions) 2007 2008 2009 Atherectomy 35.6 37.7 34.5

  12. Slide 12: Crossing Solutions

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 12 Crossing Solutions Revenue (millions) 2007 2008 2009 Crossing Solutions 11.8 16.7 21.4

  13. Slide 13: Thrombectomy

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 13 Thrombectomy Revenue (millions) 2007 2008 2009 Thrombectomy 0 3.1 6.1

  14. Slide 14: 2010 Goals

    (c)2010 Spectranetics All Rights Reserved. www.spectranetics.com 14 2010 Goals Restore growth in peripheral atherectomy revenue with launch of Turbo-Tandem Continue to work with FDA to secure clearance on ISR Initiate randomized clinical trial in the U.S. for ISR Implement fellows training and simul

Spectranetics — FY2009 Earnings Presentation on 6ix